Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas

• Ari Kassardjian ,

  Contributed equally to this work with: Ari Kassardjian, Neda A. Moatamed

  Roles Formal analysis, Investigation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America

  ⨯
• Peter I. Shintaku,

  Roles Investigation, Methodology, Visualization

  Affiliation Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America

  ⨯
• Neda A. Moatamed

  Contributed equally to this work with: Ari Kassardjian, Neda A. Moatamed

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Validation, Visualization, Writing – review & editing

  * E-mail: nmoatamed@mednet.ucla.edu

  Affiliation Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America

  http://orcid.org/0000-0002-9986-8058

  ⨯